M. Limbert

993 total citations
43 papers, 832 citations indexed

About

M. Limbert is a scholar working on Pharmacology, Molecular Medicine and Molecular Biology. According to data from OpenAlex, M. Limbert has authored 43 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pharmacology, 20 papers in Molecular Medicine and 15 papers in Molecular Biology. Recurrent topics in M. Limbert's work include Antibiotics Pharmacokinetics and Efficacy (27 papers), Antibiotic Resistance in Bacteria (20 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (7 papers). M. Limbert is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (27 papers), Antibiotic Resistance in Bacteria (20 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (7 papers). M. Limbert collaborates with scholars based in Germany, France and India. M. Limbert's co-authors include Gerhard Seibert, N. Klesel, E. Schrinner, Irvin Winkler, A. Markus, K. Seeger, U. Hadding, D Bitter-Suermann, J. BLUMBACH and B. N. GANGULI and has published in prestigious journals such as The Journal of Immunology, Antimicrobial Agents and Chemotherapy and Tetrahedron.

In The Last Decade

M. Limbert

41 papers receiving 704 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Limbert Germany 18 464 298 229 146 115 43 832
Sachiko Gotô Japan 20 346 0.7× 247 0.8× 411 1.8× 121 0.8× 162 1.4× 92 1.1k
Edwin M. Oden United States 17 492 1.1× 215 0.7× 382 1.7× 138 0.9× 96 0.8× 32 1.1k
YASUHIRO MINE Japan 22 466 1.0× 263 0.9× 372 1.6× 125 0.9× 146 1.3× 60 1.2k
N. Klesel Germany 14 351 0.8× 216 0.7× 159 0.7× 125 0.9× 87 0.8× 36 604
Paul Actor United States 17 320 0.7× 177 0.6× 277 1.2× 167 1.1× 231 2.0× 72 988
KANJI TSUCHIYA Japan 14 303 0.7× 219 0.7× 207 0.9× 152 1.0× 93 0.8× 47 652
E. Schrinner Germany 14 361 0.8× 275 0.9× 115 0.5× 150 1.0× 127 1.1× 36 576
P. Acred United Kingdom 14 311 0.7× 236 0.8× 136 0.6× 160 1.1× 145 1.3× 30 675
Katsuhisa Nakata Japan 15 184 0.4× 147 0.5× 204 0.9× 147 1.0× 96 0.8× 28 710
Axel Dalhoff Germany 13 250 0.5× 348 1.2× 201 0.9× 248 1.7× 116 1.0× 24 780

Countries citing papers authored by M. Limbert

Since Specialization
Citations

This map shows the geographic impact of M. Limbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Limbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Limbert more than expected).

Fields of papers citing papers by M. Limbert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Limbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Limbert. The network helps show where M. Limbert may publish in the future.

Co-authorship network of co-authors of M. Limbert

This figure shows the co-authorship network connecting the top 25 collaborators of M. Limbert. A scholar is included among the top collaborators of M. Limbert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Limbert. M. Limbert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vértesy, László, Hans‐Wolfram Fehlhaber, Herbert Kogler, & M. Limbert. (1996). New 4-Oxovancosamine-containing Glycopeptide Antibiotics from Amycolatopsis sp. Y-86,21022.. The Journal of Antibiotics. 49(1). 115–118. 13 indexed citations
2.
Klesel, N., et al.. (1995). Chemotherapeutic activity of levofloxacin (HR 355, DR-3355) against systemic and localized infections in laboratory animals. Journal of Antimicrobial Chemotherapy. 35(6). 805–819. 25 indexed citations
3.
Klesel, N., M. Limbert, A. Markus, et al.. (1995). Activity of Levofloxacin, Ofloxacin, D-Ofloxacin and Ciprofloxacin against Systemic and Respiratory Tract Infections in Laboratory Animals. Drugs. 49(Supplement 2). 211–214. 1 indexed citations
4.
Wagner, Ulrich, D. Müller, Peter Welzel, et al.. (1994). Moenomycin A: reactions at the lipid part. New structure-activity relations. Tetrahedron. 50(18). 5299–5308. 21 indexed citations
5.
Jani, Rajendrakumar H., J. BLUMBACH, B. N. GANGULI, et al.. (1992). Mersacidin, a new antibiotic from Bacillus In vitro and in vivo antibacterial activity.. The Journal of Antibiotics. 45(6). 839–845. 110 indexed citations
6.
Limbert, M., et al.. (1992). Influence of cefodizime on the reagibility of human leukocytes. Infection. 20(S1). S48–S50. 6 indexed citations
7.
Klesel, N., et al.. (1992). Pharmacokinetics of cefpirome administered intravenously or intramuscularly to rats and dogs. Journal of Antimicrobial Chemotherapy. 29(suppl A). 31–37. 15 indexed citations
8.
Seibert, Gerhard, et al.. (1992). The in-vitro antibacterial activity of a combination of cefpirome or cefoperazone with vancomycin against enterococci and Staphylococcus aureus. Journal of Antimicrobial Chemotherapy. 29(suppl A). 25–30. 25 indexed citations
9.
Limbert, M., Gerhard Seibert, Irvin Winkler, et al.. (1992). Antibacterial activity in vitro of cefpirome against clinical isolates causing sexually transmitted diseases. Journal of Antimicrobial Chemotherapy. 29(suppl A). 13–17. 4 indexed citations
10.
Klesel, N., et al.. (1992). RU 29 246, the active compound of the cephalosporin prodrug-ester HR 916. III. Pharmacokinetic properties and antibacterial activity in vivo.. The Journal of Antibiotics. 45(6). 922–931. 3 indexed citations
11.
Bauernfeind, A., R. Jungwirth, N. Klesel, et al.. (1992). RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. I. Antibacterial activity in vitro.. The Journal of Antibiotics. 45(4). 505–520. 12 indexed citations
12.
Markus, A., N. Klesel, M. Limbert, et al.. (1992). RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. II. Stability to .BETA.-lactamases and affinity for penicillin-binding proteins.. The Journal of Antibiotics. 45(4). 521–526. 2 indexed citations
13.
Hackler, Ulrich E., Uwe Heinz, Peter Welzel, et al.. (1992). The first enzymatic degradation products of the antibiotic moenomycin A.. Tetrahedron. 48(39). 8401–8418. 15 indexed citations
14.
Klesel, N., et al.. (1990). Comparative chemotherapeutic activity of cefpirome and imipenem in experimental infections.. The Journal of Antibiotics. 43(1). 100–106. 5 indexed citations
15.
Lattrell, Rudolf, et al.. (1988). Synthesis and structure-activity relationships in the cefpirome series. III. 7.ALPHA.-Methoxy and 7.ALPHA.-formamido analogues of cefpirome.. The Journal of Antibiotics. 41(10). 1409–1417. 2 indexed citations
16.
Klesel, N., et al.. (1987). HRE 664, a new parenteral penem. II. Evaluation of the pharmacokinetic behavior and the chemotherapeutic activity in animals.. The Journal of Antibiotics. 40(8). 1184–1192. 4 indexed citations
17.
Klesel, N., M. Limbert, K. Seeger, et al.. (1984). Cefodizime, an aminothiazolylcephalosporin. II. Comparative studies on the pharmacokinetic behavior in laboratory animals.. The Journal of Antibiotics. 37(8). 901–909. 21 indexed citations
18.
Klesel, N., M. Limbert, Gerhard Seibert, Irvin Winkler, & E. Schrinner. (1984). Cefodizime, an aminothiazolyl cephalosporin. III. Therapeutic activity against experimentally induced pneumonia in mice.. The Journal of Antibiotics. 37(12). 1712–1718. 21 indexed citations
19.
Hadding, U., et al.. (1973). Alternate Pathway of C Activation in Guinea Pig Serum: Characterization of Cofactors. The Journal of Immunology. 111(1). 286–287. 3 indexed citations
20.
Hadding, U., M. P. Dierich, Wolfgang König, et al.. (1973). Ability of the T cell‐replacing polyanion dextran sulfate to trigger the alternate pathway of complement activation. European Journal of Immunology. 3(8). 527–529. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sachiko Gotô Breakdown of academic impact, for papers by Edwin M. Oden Breakdown of academic impact, for papers by YASUHIRO MINE Breakdown of academic impact, for papers by N. Klesel Breakdown of academic impact, for papers by Paul Actor Breakdown of academic impact, for papers by KANJI TSUCHIYA Breakdown of academic impact, for papers by E. Schrinner Breakdown of academic impact, for papers by P. Acred Breakdown of academic impact, for papers by Katsuhisa Nakata Breakdown of academic impact, for papers by Axel Dalhoff
Rankless by CCL
2026